ID   FACR1_HUMAN             Reviewed;         515 AA.
AC   Q8WVX9; D3DQW8; Q5CZA3;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   10-MAY-2017, entry version 125.
DE   RecName: Full=Fatty acyl-CoA reductase 1;
DE            EC=1.2.1.n2;
DE   AltName: Full=Male sterility domain-containing protein 2;
GN   Name=FAR1; Synonyms=MLSTD2; ORFNames=UNQ2423/PRO4981;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15220348; DOI=10.1074/jbc.M406225200;
RA   Cheng J.B., Russell D.W.;
RT   "Mammalian wax biosynthesis: I. Identification of two fatty acyl-
RT   coenzyme A reductases with different substrate specificities and
RT   tissue distributions.";
RL   J. Biol. Chem. 279:37789-37797(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zheng H., Xie Y., Mao Y.;
RT   "Cloning and characterization of a putative fatty acyl reductase.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrial tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND INTERACTION WITH PEX19.
RX   PubMed=24108123; DOI=10.1074/jbc.M113.498345;
RA   Honsho M., Asaoku S., Fukumoto K., Fujiki Y.;
RT   "Topogenesis and homeostasis of fatty acyl-CoA reductase 1.";
RL   J. Biol. Chem. 288:34588-34598(2013).
RN   [9]
RP   INVOLVEMENT IN PFCRD, VARIANTS PFCRD 165-GLU--PRO-169 DELINS ASP AND
RP   GLY-365, AND CHARACTERIZATION OF VARIANTS PFCRD 165-GLU--PRO-169
RP   DELINS ASP AND GLY-365.
RX   PubMed=25439727; DOI=10.1016/j.ajhg.2014.10.003;
RA   Buchert R., Tawamie H., Smith C., Uebe S., Innes A.M., Al Hallak B.,
RA   Ekici A.B., Sticht H., Schwarze B., Lamont R.E., Parboosingh J.S.,
RA   Bernier F.P., Abou Jamra R.;
RT   "A peroxisomal disorder of severe intellectual disability, epilepsy,
RT   and cataracts due to fatty acyl-CoA reductase 1 deficiency.";
RL   Am. J. Hum. Genet. 95:602-610(2014).
CC   -!- FUNCTION: Catalyzes the reduction of saturated fatty acyl-CoA with
CC       chain length C16 or C18 to fatty alcohols.
CC       {ECO:0000269|PubMed:15220348}.
CC   -!- CATALYTIC ACTIVITY: Hexadecanal + CoA + NADP(+) = hexadecanoyl-CoA
CC       + NADPH. {ECO:0000269|PubMed:15220348}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with PEX19, the interaction is
CC       required for targeting to peroxisomes.
CC       {ECO:0000269|PubMed:24108123}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome membrane
CC       {ECO:0000269|PubMed:24108123}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:24108123}.
CC   -!- DISEASE: Peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD)
CC       [MIM:616154]: An autosomal recessive metabolic disorder clinically
CC       characterized by severe intellectual disability, early-onset
CC       epilepsy, microcephaly, congenital cataracts, growth retardation,
CC       and spasticity. {ECO:0000269|PubMed:25439727}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the fatty acyl-CoA reductase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY600449; AAT42129.1; -; mRNA.
DR   EMBL; AY423606; AAR84086.1; -; mRNA.
DR   EMBL; AY358784; AAQ89144.1; -; mRNA.
DR   EMBL; CR936619; CAI56762.1; -; mRNA.
DR   EMBL; CH471064; EAW68492.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68493.1; -; Genomic_DNA.
DR   EMBL; BC017377; AAH17377.1; -; mRNA.
DR   CCDS; CCDS7813.1; -.
DR   RefSeq; NP_115604.1; NM_032228.5.
DR   UniGene; Hs.501991; -.
DR   ProteinModelPortal; Q8WVX9; -.
DR   BioGrid; 123936; 11.
DR   IntAct; Q8WVX9; 21.
DR   STRING; 9606.ENSP00000346874; -.
DR   SwissLipids; SLP:000000208; -.
DR   iPTMnet; Q8WVX9; -.
DR   PhosphoSitePlus; Q8WVX9; -.
DR   SwissPalm; Q8WVX9; -.
DR   BioMuta; FAR1; -.
DR   DMDM; 74730902; -.
DR   EPD; Q8WVX9; -.
DR   MaxQB; Q8WVX9; -.
DR   PaxDb; Q8WVX9; -.
DR   PeptideAtlas; Q8WVX9; -.
DR   PRIDE; Q8WVX9; -.
DR   DNASU; 84188; -.
DR   Ensembl; ENST00000354817; ENSP00000346874; ENSG00000197601.
DR   GeneID; 84188; -.
DR   KEGG; hsa:84188; -.
DR   UCSC; uc001mld.4; human.
DR   CTD; 84188; -.
DR   DisGeNET; 84188; -.
DR   GeneCards; FAR1; -.
DR   HGNC; HGNC:26222; FAR1.
DR   HPA; HPA017322; -.
DR   MalaCards; FAR1; -.
DR   MIM; 616107; gene.
DR   MIM; 616154; phenotype.
DR   neXtProt; NX_Q8WVX9; -.
DR   OpenTargets; ENSG00000197601; -.
DR   PharmGKB; PA162388007; -.
DR   eggNOG; KOG1221; Eukaryota.
DR   eggNOG; ENOG410XS7R; LUCA.
DR   GeneTree; ENSGT00390000006367; -.
DR   HOGENOM; HOG000261667; -.
DR   HOVERGEN; HBG076152; -.
DR   InParanoid; Q8WVX9; -.
DR   KO; K13356; -.
DR   OMA; SINIIFH; -.
DR   OrthoDB; EOG091G062W; -.
DR   PhylomeDB; Q8WVX9; -.
DR   TreeFam; TF313011; -.
DR   BioCyc; MetaCyc:HS16231-MONOMER; -.
DR   BRENDA; 1.2.1.50; 2681.
DR   Reactome; R-HSA-8848584; Wax biosynthesis.
DR   ChiTaRS; FAR1; human.
DR   GeneWiki; MLSTD2; -.
DR   GenomeRNAi; 84188; -.
DR   PRO; PR:Q8WVX9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000197601; -.
DR   CleanEx; HS_FAR1; -.
DR   ExpressionAtlas; Q8WVX9; baseline and differential.
DR   Genevisible; Q8WVX9; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0080019; F:fatty-acyl-CoA reductase (alcohol-forming) activity; IDA:UniProtKB.
DR   GO; GO:0050062; F:long-chain-fatty-acyl-CoA reductase activity; IEA:Ensembl.
DR   GO; GO:0016491; F:oxidoreductase activity; TAS:Reactome.
DR   GO; GO:0008611; P:ether lipid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0046474; P:glycerophospholipid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0035336; P:long-chain fatty-acyl-CoA metabolic process; IDA:UniProtKB.
DR   GO; GO:0010025; P:wax biosynthetic process; TAS:Reactome.
DR   CDD; cd09071; FAR_C; 1.
DR   InterPro; IPR026055; FAR.
DR   InterPro; IPR033640; FAR_C.
DR   InterPro; IPR013120; Male_sterile_NAD-bd.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   PANTHER; PTHR11011; PTHR11011; 1.
DR   Pfam; PF07993; NAD_binding_4; 1.
DR   Pfam; PF03015; Sterile; 1.
DR   SUPFAM; SSF51735; SSF51735; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Epilepsy; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Mental retardation; NADP; Oxidoreductase;
KW   Peroxisome; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    515       Fatty acyl-CoA reductase 1.
FT                                /FTId=PRO_0000261394.
FT   TOPO_DOM      1    465       Peroxisomal. {ECO:0000255}.
FT   TRANSMEM    466    483       Helical. {ECO:0000255}.
FT   TOPO_DOM    484    515       Cytoplasmic. {ECO:0000255}.
FT   VARIANT      96     96       E -> K (in dbSNP:rs12793516).
FT                                /FTId=VAR_053800.
FT   VARIANT     165    169       EVVYP -> D (in PFCRD; results in a
FT                                complete loss of enzyme activity).
FT                                {ECO:0000269|PubMed:25439727}.
FT                                /FTId=VAR_072692.
FT   VARIANT     365    365       D -> G (in PFCRD; results in a complete
FT                                loss of enzyme activity;
FT                                dbSNP:rs724159963).
FT                                {ECO:0000269|PubMed:25439727}.
FT                                /FTId=VAR_072693.
FT   CONFLICT    275    276       LV -> PG (in Ref. 4; CAI56762).
FT                                {ECO:0000305}.
SQ   SEQUENCE   515 AA;  59357 MW;  EF5CF7CDD161BCD3 CRC64;
     MVSIPEYYEG KNVLLTGATG FLGKVLLEKL LRSCPKVNSV YVLVRQKAGQ TPQERVEEVL
     SGKLFDRLRD ENPDFREKII AINSELTQPK LALSEEDKEV IIDSTNIIFH CAATVRFNEN
     LRDAVQLNVI ATRQLILLAQ QMKNLEVFMH VSTAYAYCNR KHIDEVVYPP PVDPKKLIDS
     LEWMDDGLVN DITPKLIGDR PNTYIYTKAL AEYVVQQEGA KLNVAIVRPS IVGASWKEPF
     PGWIDNFNGP SGLFIAAGKG ILRTIRASNN ALADLVPVDV VVNMSLAAAW YSGVNRPRNI
     MVYNCTTGST NPFHWGEVEY HVISTFKRNP LEQAFRRPNV NLTSNHLLYH YWIAVSHKAP
     AFLYDIYLRM TGRSPRMMKT ITRLHKAMVF LEYFTSNSWV WNTENVNMLM NQLNPEDKKT
     FNIDVRQLHW AEYIENYCLG TKKYVLNEEM SGLPAARKHL NKLRNIRYGF NTILVILIWR
     IFIARSQMAR NIWYFVVSLC YKFLSYFRAS STMRY
//
